Share Price.com
Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Ergomed earnings boosted by 'significant' profit growth in second half

Thursday, 31st January 2019
Pharmaceutical services provider Ergomed said Thursday annual earnings were expected to meet market expectations on the back of cost cuts and a 'significant' turnaround in profits seen in the second half.

Net Service fee revenues for 2018 were expected to be approximately £46.5m, up from £39.6m, in line with current market expectations, the company said.

Growth in both pharmacovigilance and CRO was anticipated to be broadly in line with expectations.

New business sales rose to £76m for the year, from £54m a year earlier, bolstering the Ergomed's order book. The backlog of orders at the end of 2018 was expected to be approximately £106m, up from £88m a year earlier.

'Based on our contracted backlog and re-aligned cost base, I am optimistic we can deliver our 2019 growth targets,' said Dr Miroslav Reljanovic, Executive Chairman of Ergomed.


At 10:07am: (LON:ERGO) Ergomed Plc share price was +2.5p at 175p



Story provided by StockMarketWire.com

Related Shares: Ergomed

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.